A Taiwanese life science company with local offices in Burlington is establishing a new research facility at 36 Crosby Drive in Bedford.
PharmaEssentia will employ 25 scientists at its new 11,675-square-foot Innovation Research Center.
Founded in 2003, PharmaEssentia has global headquarters in Taipei, Taiwan and specializes in hematology and oncology research. The company gained FDA approval in 2021 for its Besremi drug used to treat a form of blood cancer.
The company also has U.S. headquarters at 35 Corporate Drive in Burlington.
Hunneman’s Patrick Grady, Jim Boudrot and Steve James represented the tenant in the lease negotiation.






